Author: Ray El Boustany

Interferon Regulatory Factor 5 represses oxidative respiration in human and murine macrophages by inhibition of mitochondrial matrix protein GHITM Our […]

Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease Non-alcoholic fatty liver disease (NAFLD) is the […]

Use of Dipeptidyl Peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis […]

The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages Huang Z […]

Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes Through […]

Impact of BMI on prevalence of coronary atherosclerotic lesions in non-smoking premenopausal diabetic women: A monocentric study Laurence Salle, Margot […]

Coronary Artery Calcification and Complications in Patients With COVID-19 JF. Gautier has recently contributed to a cross-sectional study at Lariboisière […]

Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective data from the epidemiological […]

Adipocyte Reprogramming by the Transcriptional Coregulator GPS2 Impacts Beta Cell Insulin Secretion Glucose homeostasis is maintained through organ crosstalk that […]

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes The year 2020 has been marred by […]